114 related articles for article (PubMed ID: 23809996)
1. The role of diabetes and other co-morbidities on survival after esophageal cancer surgery in a population-based study.
Backemar L; Djärv T; Wikman A; Johar A; Ross P; Lagergren P; Lagergren J
Am J Surg; 2013 Oct; 206(4):539-43. PubMed ID: 23809996
[TBL] [Abstract][Full Text] [Related]
2. Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study.
Rutegård M; Lagergren P; Rouvelas I; Mason R; Lagergren J
Eur J Surg Oncol; 2012 Jul; 38(7):555-61. PubMed ID: 22483704
[TBL] [Abstract][Full Text] [Related]
3. Impact of co-morbidity on mortality after oesophageal cancer surgery.
Backemar L; Lagergren P; Johar A; Lagergren J
Br J Surg; 2015 Aug; 102(9):1097-105. PubMed ID: 26059747
[TBL] [Abstract][Full Text] [Related]
4. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.
Koppert LB; Lemmens VE; Coebergh JW; Steyerberg EW; Wijnhoven BP; Tilanus HW; Janssen-Heijnen ML
Br J Surg; 2012 Dec; 99(12):1693-700. PubMed ID: 23132417
[TBL] [Abstract][Full Text] [Related]
5. Impact of hospital volume on long-term survival after esophageal cancer surgery.
Rouvelas I; Lindblad M; Zeng W; Viklund P; Ye W; Lagergren J
Arch Surg; 2007 Feb; 142(2):113-7; discussion 118. PubMed ID: 17309961
[TBL] [Abstract][Full Text] [Related]
6. University hospital status and prognosis following surgery for esophageal cancer.
Markar SR; Wahlin K; Lagergren P; Lagergren J
Eur J Surg Oncol; 2016 Aug; 42(8):1191-5. PubMed ID: 27288216
[TBL] [Abstract][Full Text] [Related]
7. Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update.
Rutegård M; Charonis K; Lu Y; Lagergren P; Lagergren J; Rouvelas I
Surgery; 2012 Nov; 152(5):903-10. PubMed ID: 22657730
[TBL] [Abstract][Full Text] [Related]
8. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden.
Viklund P; Lindblad M; Lu M; Ye W; Johansson J; Lagergren J
Ann Surg; 2006 Feb; 243(2):204-11. PubMed ID: 16432353
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
[TBL] [Abstract][Full Text] [Related]
11. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
12. Improving outcomes after gastroesophageal cancer resection: can Japanese results be reproduced in Western centers?
Hanna GB; Boshier PR; Knaggs A; Goldin R; Sasako M
Arch Surg; 2012 Aug; 147(8):738-45. PubMed ID: 22911070
[TBL] [Abstract][Full Text] [Related]
13. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.
Sundelöf M; Lagergren J; Ye W
Eur J Cancer; 2008 Jul; 44(11):1566-71. PubMed ID: 18434132
[TBL] [Abstract][Full Text] [Related]
14. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
[TBL] [Abstract][Full Text] [Related]
15. Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
Markar SR; Mackenzie H; Lagergren P; Lagergren J
Ann Surg; 2018 Jul; 268(1):100-105. PubMed ID: 28394868
[TBL] [Abstract][Full Text] [Related]
16. The influence of surgical factors on persisting symptoms 3 years after esophageal cancer surgery: a population-based study in Sweden.
van der Schaaf M; Rutegård M; Lagergren P
Ann Surg Oncol; 2013 May; 20(5):1639-45. PubMed ID: 23271489
[TBL] [Abstract][Full Text] [Related]
17. The impact of radiation therapy sequencing on survival and cardiopulmonary mortality in the combined modality treatment of patients with esophageal cancer.
Wojcieszynski AP; Berman AT; Wan F; Plastaras JP; Metz JM; Mitra N; Apisarnthanarax S
Cancer; 2013 Jun; 119(11):1976-84. PubMed ID: 23400669
[TBL] [Abstract][Full Text] [Related]
18. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors.
Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H
Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216
[TBL] [Abstract][Full Text] [Related]
19. Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study.
Derogar M; Sadr-Azodi O; Johar A; Lagergren P; Lagergren J
J Clin Oncol; 2013 Feb; 31(5):551-7. PubMed ID: 23295792
[TBL] [Abstract][Full Text] [Related]
20. Time shift in early postoperative mortality after oesophagectomy for cancer.
Rutegård M; Lagergren P; Johar A; Lagergren J
Ann Surg Oncol; 2015 Sep; 22(9):3144-9. PubMed ID: 25649859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
